University of Kentucky Markey Cancer Center | Strategic Alliance Partners

Latest from University of Kentucky Markey Cancer Center


NCDB Analysis Shows Survival Benefit With Surgery vs Chemoradiation in NSCLC

April 10, 2023

Janeesh Sekkath Veedu, MBBS, discusses the need for research comparing outcomes with surgery-based treatment vs CRT and immunotherapy in stage IIIA NSCLC, shares findings from a NCDB analysis, and emphasizes the importance of continuing this research as updated data become available.

Gaining Insight Into the Management of Gastrointestinal Malignancies

December 28, 2020

Faculty from a recent Institutional Perspectives in Cancer webinar on gastrointestinal cancer hosted by the University of Kentucky discuss the current paradigms in hepatocellular carcinoma, colorectal cancer, and pancreatic cancer.

University of Kentucky Lab Seeks to Decode Epigenetic Signals in Cancer

June 30, 2019

Although many labs study cancer as an all-or-nothing process, putting all metastable hybrid stages in the same bin, our laboratory at the University of Kentucky is exploring carcinogenesis as a continuum, from initiation through progression to maintenance. This approach has prompted us to focus on the role of epigenetics in cancer development.